prulifloxacin has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasi, F; Centanni, S; Del Vecchio, A; Dionisio, P; Rosignoli, MT; Schaberg, T | 1 |
| Blasi, F; Bonizzoni, E; Campanini, M; Casali, A; Colagrande, P; Giusti, M; Gussoni, G; Iori, I; Mazzone, A; Politi, C; Sgambato, F; Valerio, A | 1 |
| Biscione, G; Cazzola, M; Crigna, G; Pasqua, F | 1 |
3 trial(s) available for prulifloxacin and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Dioxolanes; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Forced Expiratory Volume; Humans; Levofloxacin; Male; Middle Aged; Piperazines; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Dioxolanes; Disease Progression; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Piperazines; Pulmonary Disease, Chronic Obstructive; Recurrence; Retreatment; Single-Blind Method; Symptom Assessment; Symptom Flare Up; Treatment Failure | 2016 |
Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacteria; Dioxolanes; Female; Fluoroquinolones; Humans; Male; Piperazines; Pulmonary Disease, Chronic Obstructive; Smoking; Sputum | 2008 |